LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Chemotherapy resumption in ovarian cancer patient diagnosed with COVID-19

Photo by nci from unsplash

Highlights • Chemotherapy resumption after convalescence from COVID-19 is safe and feasible.• No guidelines exist for resumption of chemotherapy in patients with COVID-19.• Cancer patients on chemotherapy may develop SARS-CoV-2… Click to show full abstract

Highlights • Chemotherapy resumption after convalescence from COVID-19 is safe and feasible.• No guidelines exist for resumption of chemotherapy in patients with COVID-19.• Cancer patients on chemotherapy may develop SARS-CoV-2 antibodies less frequently.

Keywords: chemotherapy; ovarian cancer; resumption ovarian; resumption; chemotherapy resumption

Journal Title: Gynecologic Oncology Reports
Year Published: 2020

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.